ReviewArchives of toxicology2026
PFAS and One Health: integrating human, animal, and environmental perspectives.
Review in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Per- and polyfluoroalkyl substances (PFAS)-ubiquitous, persistent, and bioaccumulative-pose a cross-cutting threat to human, animal, and environmental health. Their resistance to degradation and global dissemination demand an integrated One Health framework to address their complex, interdependent risks across ecosystems, wildlife, and public health. This review synthesizes current knowledge on PFAS, highlighting their anthropogenic origins, environmental persistence, and global dispersion. Common exposure pathways, such as dietary intake, contaminated drinking water, and maternal transfer, lead to convergent toxicological outcomes across species, including immunotoxicity, reproductive and developmental impairments, and carcinogenicity, validating the use of cross-species data in risk assessment and reinforcing the need for integrated protective strategies. Vulnerable human populations and wildlife face disproportionate risks, with the latter acting as both sentinels and exposure sources. Despite regulatory efforts, the ongoing use and development of replacement compounds sustain PFAS as a global concern. Effectively addressing this challenge requires a coordinated, cross-sectoral strategy that integrates environmental monitoring, transdisciplinary research, and harmonized regulatory frameworks. The One Health paradigm provides the essential model for developing these collaborative solutions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.